Kiniksa Pharmaceuticals International (KNSA) Treasury Shares (2017 - 2026)

Kiniksa Pharmaceuticals International has reported Treasury Shares for 10 years, with the latest figure at $421007.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 611.92% year-over-year to $421007.0; the trailing twelve-month figure through Mar 2026 stood at $421007.0 (up 611.92% YoY), and the FY2025 full-year result was $2.1 million, up 3407.27% from the prior year.
• Treasury Shares for Q1 2026 stood at $421007.0, down from $2.1 million in the prior quarter.
• The five-year high for Treasury Shares was $2.4 million in Q4 2023, with the low at $59137.0 in Q3 2024.
• Historically, Treasury Shares has averaged $1.4 million across 5 years, with a median of $1.7 million in 2023.
• Annual changes were most pronounced in 2024 — Treasury Shares slumped 97.53% — and 2025, when it soared 3623.69%.
• Kiniksa Pharmaceuticals International's Treasury Shares stood at $1.7 million in 2022, then soared by 37.56% to $2.4 million in 2023, then tumbled by 97.53% to $59137.0 in 2024, then surged by 3407.27% to $2.1 million in 2025, then tumbled by 79.7% to $421007.0 in 2026.
• The last three Treasury Shares figures came in at $421007.0 (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.